Dana Investment Advisors Inc. Has $10.08 Million Stake in Select Medical Holdings Corporation $SEM

Dana Investment Advisors Inc. raised its position in Select Medical Holdings Corporation (NYSE:SEM) by 29.3% during the 4th quarter, HoldingsChannel.com reports. The firm owned 678,545 shares of the health services provider’s stock after purchasing an additional 153,924 shares during the period. Dana Investment Advisors Inc.’s holdings in Select Medical were worth $10,076,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. State of Alaska Department of Revenue boosted its stake in shares of Select Medical by 1.5% in the fourth quarter. State of Alaska Department of Revenue now owns 63,370 shares of the health services provider’s stock valued at $940,000 after buying an additional 935 shares during the period. Wilmington Savings Fund Society FSB boosted its stake in shares of Select Medical by 20.9% in the third quarter. Wilmington Savings Fund Society FSB now owns 5,784 shares of the health services provider’s stock valued at $74,000 after buying an additional 999 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH boosted its stake in shares of Select Medical by 9.7% in the fourth quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 11,475 shares of the health services provider’s stock valued at $171,000 after buying an additional 1,014 shares during the period. Oregon Public Employees Retirement Fund boosted its stake in shares of Select Medical by 5.1% in the third quarter. Oregon Public Employees Retirement Fund now owns 24,816 shares of the health services provider’s stock valued at $319,000 after buying an additional 1,200 shares during the period. Finally, California State Teachers Retirement System boosted its stake in shares of Select Medical by 1.4% in the second quarter. California State Teachers Retirement System now owns 102,230 shares of the health services provider’s stock valued at $1,552,000 after buying an additional 1,418 shares during the period. Institutional investors and hedge funds own 89.48% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently issued reports on SEM shares. Zacks Research upgraded Select Medical from a “strong sell” rating to a “hold” rating in a research note on Monday, May 4th. Royal Bank Of Canada restated a “sector perform” rating and set a $16.50 target price (down from $19.00) on shares of Select Medical in a research note on Tuesday, March 3rd. Mizuho restated a “neutral” rating and set a $16.50 target price (down from $17.00) on shares of Select Medical in a research note on Tuesday. Wall Street Zen cut Select Medical from a “buy” rating to a “hold” rating in a research note on Monday, March 9th. Finally, Benchmark cut Select Medical from a “buy” rating to a “hold” rating in a research note on Wednesday, March 4th. One investment analyst has rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $15.50.

Select Medical Stock Up 0.3%

NYSE SEM opened at $16.51 on Friday. The business has a fifty day moving average price of $16.35 and a two-hundred day moving average price of $15.40. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.15 and a quick ratio of 1.15. Select Medical Holdings Corporation has a fifty-two week low of $11.65 and a fifty-two week high of $16.99. The stock has a market capitalization of $2.05 billion, a PE ratio of 15.57, a PEG ratio of 0.95 and a beta of 1.02.

Select Medical (NYSE:SEM) last released its earnings results on Thursday, April 30th. The health services provider reported $0.36 earnings per share for the quarter, missing the consensus estimate of $0.43 by ($0.07). The business had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.41 billion. Select Medical had a return on equity of 6.62% and a net margin of 2.42%.The firm’s revenue for the quarter was up 5.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.44 earnings per share. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. Equities analysts expect that Select Medical Holdings Corporation will post 1.26 earnings per share for the current fiscal year.

Select Medical Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, May 28th. Stockholders of record on Thursday, May 14th will be issued a dividend of $0.0625 per share. The ex-dividend date is Thursday, May 14th. This represents a $0.25 annualized dividend and a dividend yield of 1.5%. Select Medical’s dividend payout ratio is 23.58%.

Select Medical declared that its Board of Directors has initiated a stock repurchase program on Thursday, February 19th that authorizes the company to buyback $1.00 billion in shares. This buyback authorization authorizes the health services provider to purchase up to 49.5% of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s board believes its shares are undervalued.

Select Medical Company Profile

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.